Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 2,098 shares at $362.45 ($755K) on 2021-12-01, disclosed to the SEC on 2021-12-02.
Open-market sale of $755k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $357.32 | 530 | $189K | 25.1% |
| 2 | $357.32 | 530 | $189K | 25.1% |
| 3 | $362.45 | 519 | $188K | 24.9% |
| 4 | $362.45 | 519 | $188K | 24.9% |
| Total | $359.86 avg | 2,098 | $755K | 100% |
| Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |
| BGNE | SELL | 2021-09-22 | $3.6M | — | Filing → |